Skip to main content
Search
Search
Toggle navigation
About Terumo India
Col 1
About Terumo India
Col 2
Dear Stakeholders
Who We Are
At a Glance
Group Mission
Message from
Col 3
Leadership Team
History
Brand Video "Our Promise"
Response to COVID-19
Business Overview
Col 1
Business Overview
Col 2
TIS Division (Terumo Interventional Systems)
Cardiovascular Division (Terumo Cardiovascular)
Vascular Graft Division (Terumo Aortic)
Col 3
Life Care Solutions Division
Pharmaceutical Solutions Division
Sustainability
col 1
Sustainability
col 2
CSR Initiatives
CSR Policy & Committee
col 3
Award & Recognition
Creating a Diverse and Inclusive Workplace
Technology
col 1
Technology Overview
col 2
Basic Information
col 3
Stories - Our Technologies
News
Col 1-4
News
Col 2-2
Col 5-5
March 21, 2025
Corporate
TerumoCares Press Release
Col 4-5
October 14, 2024
Medical
Terumo India celebrated Terumo Patient's Day 2024, Honoring Patient-Centric Care and Innovation
Col 2-4
August 8, 2024
Medical
Terumo India launches TREO® Abdominal Stent-graft system
Col 3-4
February 12, 2024
Medical
Terumo India Certified as Great Place to Work® for The Third Time
Col 4-4
December 06, 2022
Corporate
Terumo Announces Launch of Drug-Device Combination Product Co-Developed with Kyowa Kirin
Global Network
Col 1
Global Network
Col 2
Japan
North America
South America
Col 3
EMEA
Greater China
Asia and Pacific
Home
TIS Division (Terumo Interventional Systems)
Interventional Oncology
Interventional Oncology
LifePearl™
LifePearl™
Learn More →
Occlusafe™
Occlusafe™
Learn More →
RADIFOCUS™ Glidecath™ R.A.V.I. MG1/MG2
RADIFOCUS™ Glidecath™ R.A.V.I. MG1/MG2
Learn More →
Radifocus® Glidecath®
Radifocus® Glidecath®
Learn More →
Guidewire® GT
Guidewire® GT
Learn More →
Progreat λ™
Progreat λ™
Learn More →
LifePearl™
Read more
about LifePearl™
Occlusafe™
Read more
about Occlusafe™
RADIFOCUS™ Glidecath™ R.A.V.I. MG1/MG2
Read more
about RADIFOCUS™ Glidecath™ R.A.V.I. MG1/MG2
Radifocus® Glidecath®
Read more
about Radifocus® Glidecath®
Guidewire® GT
Read more
about Guidewire® GT
Progreat λ™
Read more
about Progreat λ™
Subscribe to Interventional Oncology
Contact
Us
Top